The National Kidney Foundation is accepting abstracts for poster presentations and publication at the upcoming spring clinical meeting in May. Accepted abstracts will be published in the May 2012 issue of the AJKD. Posters accepted and presented will…
For those headed to Philly check out the Kidney Week App on the ASN website. Nice way to organize your itinerary, follow the Twitter feed and keep maps handy.
Former RFN editor Matt Sparks, along with quite a cast of others have helped to launch eAJKD, a companion blog to AJKD. Check it out.
I read a nice review of Fabry’s disease recently, and was surprised to read that its prevalence in ESRD may be as high as 1-2%. That figure is likely an underestimate, given the frequent failure to screen for…
And now for something totally exciting—a post on water treatment in dialysis. Dr Daniel Coyne of Washington University gave a great review on this topic at the Brigham Renal Board Review course this week. Here is the basic…
When one is just beginning as a nephrology fellow, it may seem as if all the major glomerular diseases (e.g., membranous nephropathy, FSGS, lupus, etc) are all treated with the same protocols and same immunosuppressive agents: steroids, Cytoxan,…
As an intern, and I’m sure many can relate to this story, I remember trailing after the team, disheveled and exhausted as we rounded endlessly postcall one day. Our hospital had the county jail contract and as we…
I’ve had the privilege of being a part of the care team for several patients who have participated in Stanford’s Immune Tolerance program here in Palo Alto. The idea behind the program is pretty cool: create chimerism (the…
Lifetime immunosuppressive drug coverage is part of protecting the health of kidney transplant recipients and under current medicare rules this coverage only extends for 36 months post transplant. During this period medicare covers 80% of immunosuppressant drug costs,…
